showed a trendp = 0.076
Subgroup analysis of patients starting ART pre-trial showed a trend toward improved outcomes (p = 0.076) but analysis of those starting ART during the trial was not significant (p = 0.30).
Subgroup analysis of patients starting ART pre-trial showed a trend toward improved outcomes (p = 0.076) but analysis of those starting ART during the trial was not significant (p = 0.30).
Discussion This trial found that a PHW intervention was associated with decreased virologic failure rates among patients on longer-term ART (≥96 weeks) with a significant trend of declining risk for virologic failures over time compared to the control arm.